In addition, miR-375 plays a cancer-promoting role in prostate cancer by influencing the epigenetic regulation of transcriptional programs through its ability to directly target the polycomb complex member CBX7 (Pickl et al., 2016). Here, CBX7 is linked to prostate carcinoma.